A detailed history of Qube Research & Technologies LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 329,557 shares of LLY stock, worth $268 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
329,557
Previous 172,269 91.3%
Holding current value
$268 Million
Previous $134 Million 122.64%
% of portfolio
0.48%
Previous 0.22%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $114 Million - $143 Million
157,288 Added 91.3%
329,557 $298 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $111 Million - $149 Million
-187,660 Reduced 52.14%
172,269 $134 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $29.2 Million - $34.4 Million
-55,544 Reduced 13.37%
359,929 $210 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $181 Million - $249 Million
415,473 New
415,473 $223 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $8.03 Million - $9.15 Million
27,095 Added 78.28%
61,710 $20 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $31.8 Million - $37.4 Million
-114,161 Reduced 76.73%
34,615 $11.2 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $34.9 Million - $43.4 Million
148,776 New
148,776 $42.6 Million
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $21.1 Million - $26.2 Million
-93,983 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $5.19 Million - $6.39 Million
23,435 Added 33.22%
93,983 $21.7 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $798,933 - $1.03 Million
-4,425 Reduced 5.9%
70,548 $16.2 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $2.86 Million - $3.7 Million
17,408 Added 30.24%
74,973 $14 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $10.5 Million - $13.9 Million
-80,797 Reduced 58.4%
57,565 $9.72 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $15.9 Million - $18.4 Million
108,511 Added 363.51%
138,362 $20.5 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $3.85 Million - $4.64 Million
28,248 Added 1762.2%
29,851 $4.9 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $190,837 - $236,202
1,603 New
1,603 $222,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $388,012 - $480,588
-3,629 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $987,487 - $1.07 Million
-9,247 Reduced 71.82%
3,629 $406,000
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $3.65 Million - $4.26 Million
-32,950 Reduced 71.9%
12,876 $1.43 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $4.79 Million - $5.63 Million
43,004 Added 1523.88%
45,826 $5.95 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $1.1 Million - $1.23 Million
-10,357 Reduced 78.59%
2,822 $327,000
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.1 Million - $1.38 Million
12,814 Added 3510.68%
13,179 $1.41 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $52,535 - $60,294
-694 Reduced 65.53%
365 $31,000
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $78,588 - $92,768
1,059 New
1,059 $81,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.